L. Chiarugi

Elevated Tissue Factor and Tissue Factor Pathway Inhibitor Circulating Levels in Ischaemic Heart Disease Patients

Anna Maria Gori, Sandra Fedi, L. Chiarugi et al. · Thrombosis and Haemostasis · 1998 · 123 citations

Hypertension, Heart Failure, Immunology +20

Postprocedural PAI-1 Activity is a Risk Marker of Subsequent Clinical Restenosis in Patients Both with and without Stent Implantation After Elective Balloon PTCA

Domenico Prisco, Sandra Fedi, Emilia Antonucci et al. · Thrombosis Research · 2001 · 24 citations

Percutaneous Coronary Intervention, Vascular Disease, Cardiovascular Disease +11

Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination

D. Poli, L. Chiarugi, M. Capanni et al. · Blood Coagulation & Fibrinolysis · 2002 · 24 citations

Vaccination, Thrombosis, Vaccine Safety +15

Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty

L. Chiarugi · Atherosclerosis · 2001 · 21 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Vascular Surgery +11

The influence of smoking on von Willebrand factor is already manifest in healthy adolescent females: the Floren-teen (Florence Teenager) Study

Domenico Prisco, Sandra Fedi, Tamara Brunelli et al. · International Journal of Clinical & Laboratory Research · 1999 · 10 citations

Tobacco Control, Substance Abuse, Substance Use +11